Jennifer Zelmer’s Post

“Without data, you don’t know if you have a problem, you don't know if you’re making any headway in solving that problem, and you don't know whether the interventions that you’re trying to test or implement are holding," said Michael Posencheg, MD, Associate Chief for Clinical Affairs at the Children's Hospital of Philadelphia. For teams who may feel intimidated by the prospect of measurement, Posencheg offers a helpful concept: “just enough” data. “Teams sometimes feel like they need to have all of the data to make a decision about something,” he said in a recent interview. “I think many teams get into this ‘analysis paralysis,’ where all they want to do is look at all the available data before making a change.” The impulse to be comprehensive, while understandable, can needlessly stall progress. https://lnkd.in/eznbeJyk

“Without data, you don’t know if you have a problem, you don't know if you’re making any headway in solving that problem, and you don't know whether the interventions that you’re trying to test or implement are holding," said Michael Posencheg, MD, Associate Chief for Clinical Affairs at the Children's Hospital of Philadelphia. For teams who may feel intimidated by the prospect of measurement, Posencheg offers a helpful concept: “just enough” data. “Teams sometimes feel like they need to have all of the data to make a decision about something,” he said in a recent interview. “I think many teams get into this ‘analysis paralysis,’ where all they want to do is look at all the available data before making a change.” The impulse to be comprehensive, while understandable, can needlessly stall progress. https://lnkd.in/eznbeJyk

“Without data, you don’t know if you have a problem, you don't know if you’re making any headway in solving that problem, and you don't know whether the interventions that you’re trying to test or implement are holding," said Michael Posencheg, MD, Associate Chief for Clinical Affairs at the Children's Hospital of Philadelphia. For teams who may feel intimidated by the prospect of measurement, Posencheg offers a helpful concept: “just enough” data. “Teams sometimes feel like they need to have all of the data to make a decision about something,” he said in a recent interview. “I think many teams get into this ‘analysis paralysis,’ where all they want to do is look at all the available data before making a change.” The impulse to be comprehensive, while understandable, can needlessly stall progress. https://lnkd.in/eznbeJyk

“Without data, you don’t know if you have a problem, you don't know if you’re making any headway in solving that problem, and you don't know whether the interventions that you’re trying to test or implement are holding," said Michael Posencheg, MD, Associate Chief for Clinical Affairs at the Children's Hospital of Philadelphia. For teams who may feel intimidated by the prospect of measurement, Posencheg offers a helpful concept: “just enough” data. “Teams sometimes feel like they need to have all of the data to make a decision about something,” he said in a recent interview. “I think many teams get into this ‘analysis paralysis,’ where all they want to do is look at all the available data before making a change.” The impulse to be comprehensive, while understandable, can needlessly stall progress. https://lnkd.in/eznbeJyk

“Without data, you don’t know if you have a problem, you don't know if you’re making any headway in solving that problem, and you don't know whether the interventions that you’re trying to test or implement are holding," said Michael Posencheg, MD, Associate Chief for Clinical Affairs at the Children's Hospital of Philadelphia. For teams who may feel intimidated by the prospect of measurement, Posencheg offers a helpful concept: “just enough” data. “Teams sometimes feel like they need to have all of the data to make a decision about something,” he said in a recent interview. “I think many teams get into this ‘analysis paralysis,’ where all they want to do is look at all the available data before making a change.” The impulse to be comprehensive, while understandable, can needlessly stall progress. https://lnkd.in/eznbeJyk

On March 28th, join our webinar with Revvity Signals to learn how the transition to fast, flexible clinical analytics can help you answer clinical questions and deliver insights into live data issues in real-time rather than prior to submission. Reserve your spot: https://lnkd.in/ev6T8Kw2 Speakers: ◽ Regina Norelli, Senior Director, Clinical Data Management, Replimune ◽ Brent Meyers, MBA, Exec. Director, Clinical Analytics, Revvity Signals ◽ Philip Ross, PhD Strategic Clinical Analytics, Revvity Signals ◽ Anna Billiard, Analytics Program Manager, Revvity Signals